SCHEMBL6013601

SCHEMBL6013601

CC1(C)CCCC(C)(C)N1OC(=O)CCCCC(=O)ON1C(C)(C)CCCC1(C)C

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 2/20 0.35
NFKB1 P19838 1/20 0.35
CYP2C19 P33261 1/20 0.35
NAAA Q02083 2/20 0.35
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
DGKA P23743 1/20 0.31
EPHX2 P34913 2/20 0.30
ALDH1A1 P00352 2/20 0.30
USP2 O75604 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27703376 0.98 NAAA (0.38) KMT2AMEN1GAATSHRNFKB1
SCHEMBL28288158 0.98 NAAA (0.38) KMT2AMEN1GAATSHRNFKB1
SCHEMBL194968 0.98 NAAA (0.38) KMT2AMEN1GAATSHRNFKB1
SCHEMBL4336157 0.96 KMT2A (0.38) KMT2AMEN1GAATSHRNFKB1
SCHEMBL27403917 0.93 TSHR (0.40) KMT2AMEN1GAATSHRNFKB1
SCHEMBL30992149 0.93 KMT2A (0.38) KMT2AMEN1GAATSHRNFKB1
SCHEMBL195275 0.92 TSHR (0.37) KMT2AMEN1GAATSHRNFKB1
SCHEMBL716439 0.92 TSHR (0.39) KMT2AMEN1TSHRNFKB1LMNA
SCHEMBL15902712 0.92 NAAA (0.47) KMT2AMEN1TSHRNAAALMNA
SCHEMBL4341466 0.92 NAAA (0.47) KMT2AMEN1TSHRNAAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-58049737-A None JP disclosed
EP-3520845-B1 SYRINGE ASSEMBLY, PREFILLED SYRINGE, SEAL CAP FOR BARREL WITH PUNCTURE NEEDLE, AND SYRINGE ASSEMBLY PACKAGE TERUMO CORP (JP) 2024-04-17 EP disclosed
EP-3338839-B1 SYRINGE ASSEMBLY, PRE-FILLED SYRINGE, SEALING CAP FOR OUTER TUBE AND PACKAGE FOR SYRINGE ASSEMBLY TERUMO CORP (JP) 2023-03-15 EP disclosed
CN-113861102-A Preparation and application of hindered amine light stabilizer 安阳加成新材料科技有限公司 2021-12-31 CN disclosed
EP-2974762-B1 SYRINGE ASSEMBLY, SYRINGE ASSEMBLY PACKAGING, AND PRE-FILLED SYRINGE TERUMO CORP (JP) 2021-12-08 EP disclosed
EP-2974761-B1 SYRINGE ASSEMBLY, SYRINGE ASSEMBLY PACKAGING, SEAL CAP FOR OUTER CYLINDER, AND PRE-FILLED SYRINGE TERUMO CORP (JP) 2020-08-12 EP disclosed
US-10549048-B2 Syringe assembly, syringe assembly package body, seal cap for barrel, and prefilled syringe TERUMO KABUSHIKI KAISHA (JP) 2020-02-04 US disclosed
EP-3520845-A1 SYRINGE ASSEMBLY, PREFILLED SYRINGE, SEAL CAP FOR BARREL WITH PUNCTURE NEEDLE, AND SYRINGE ASSEMBLY PACKAGE Terumo Kabushiki Kaisha (JP) 2019-08-07 EP disclosed
US-20190217019-A1 ASSEMBLY FOR SYRINGE, PREFILLED SYRINGE, SEAL CAP FOR PIERCING NEEDLE-ATTACHED BARREL, AND PACKAGE FOR ASSEMBLY FOR SYRINGE TERUMO KABUSHIKI KAISHA (JP) 2019-07-18 US disclosed
EP-3192549-B1 SYRINGE ASSEMBLY, SYRINGE ASSEMBLY PACKAGING, OUTER CYLINDER SEAL CAP, AND PREFILLED SYRINGE TERUMO CORP (JP) 2019-07-17 EP disclosed
US-20040002606-A1 Process for the synthesis for alkoxy amines and their use in controlled radical polymerization BAYER AKTIENGESELLSCHAFT (DE) 2004-01-01 US disclosed
US-20030236368-A1 PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE BAYER AKTIENGESELLSCHAFT (DE) 2003-12-25 US disclosed
US-20030229161-A1 Low-friction, high-dispersion synthetic resin compositon containing fine particles of RB ceramic or CRB ceramic and a method for its preparation MINEBEA, CO., LTD. 2003-12-11 US disclosed
US-6383982-B1 DYE DEVELOPERS FOR COLORING, METAL SALICYLATE AND POLYESTER POLYOLS WITH CARBONATE OR ESTER MITSUI CHEMICALS, INC. (JP) 2002-05-07 US disclosed
EP-1116571-A1 BLOW MOLDING METHOD AND BLOW MOLDED PRODUCT IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2001-07-18 EP disclosed
EP-1052112-A2 Color developer composition, aqueous dispersion, recording sheet and color developing ink Mitsui Chemicals, Inc. (JP) 2000-11-15 EP disclosed
EP-0812882-A1 LONG-FIBERGLASS REINFORCED POLYOLEFIN MOLDINGS IMPROVED IN WEATHERING RESISTANCE AND COMPOSITIONS USEFUL AS THE RAW MATERIAL THEREFOR KAWASAKI STEEL CORPORATION (JP) 1997-12-17 EP disclosed
US-4569736-A HINDERED AMINE,PHENOL, OR PHOSPHOMORUS ESTER RADIATION RESISTANCE ADDITIVE TERUMO KABUSHIKI KAISHA (JP) 1986-02-11 US disclosed
JP-S5849737-A POLYOLEFIN COMPOSITION WITH RESISTANCE TO GAMMA RAY IRRADIATION MITSUBISHI PETROCHEM CO LTD 1983-03-24 JP disclosed
JP-S05849737-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236368-A1 PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE NOS1, NOS2, CBR1 KMT2A 1259/4885MEN1 2727/4885GAA 2494/4885
US-20040002606-A1 Process for the synthesis for alkoxy amines and their use in controlled radical polymerization ALKBH3, MAOB, ALKBH1 KMT2A 1426/4885MEN1 2382/4885GAA 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.